Trials / Terminated
TerminatedNCT01792583
The Nuvigil and Provigil Pregnancy Registry
The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 191 (actual)
- Sponsor
- Cephalon, Inc. · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during pregnancy.
Detailed description
Both the prospective and the retrospective data are captured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Modafinil/armodafinil |
Timeline
- Start date
- 2009-06-30
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2013-02-15
- Last updated
- 2024-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01792583. Inclusion in this directory is not an endorsement.